VisionWave Holdings Inc (NASDAQ:VWAV – Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock traders purchased 5,501 call options on the stock. This represents an increase of 426% compared to the average daily volume of 1,046 call options.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of VisionWave in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, VisionWave presently has an average rating of “Sell”.
View Our Latest Report on VWAV
VisionWave Price Performance
VisionWave (NASDAQ:VWAV – Get Free Report) last posted its earnings results on Friday, October 3rd. The company reported ($0.15) EPS for the quarter.
Institutional Investors Weigh In On VisionWave
A hedge fund recently bought a new stake in VisionWave stock. Yorkville Advisors Global LP bought a new position in VisionWave Holdings Inc (NASDAQ:VWAV – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 200,000 shares of the company’s stock, valued at approximately $1,906,000. VisionWave accounts for about 0.4% of Yorkville Advisors Global LP’s holdings, making the stock its 9th largest holding. Yorkville Advisors Global LP owned about 1.33% of VisionWave at the end of the most recent quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.
About VisionWave
VisionWave Technologies Inc is a defense development company focused on integrating advanced artificial intelligence and autonomous solutions across air, ground and sea domains. VisionWave Technologies Inc, formerly known as Bannix Acquisition Corp., is based in WILMINGTON, Del.
Further Reading
- Five stocks we like better than VisionWave
- A month before the crash
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for VisionWave Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VisionWave and related companies with MarketBeat.com's FREE daily email newsletter.
